Sheldon Bastacky
Impact in
- Nephrology top 1%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
- Urology top 1%
Papers in
-
- Renal cell carcinoma treatment 10
-
- Renal and related cancers 14
- Co-authors
- Patrick C. Walsh (3 shared papers)Jonathan I. Epstein (3 shared papers)John P. Johnson (5 shared papers)Youhua Liu (7 shared papers)Stevan P. Tofovic (10 shared papers)Rajiv Dhir (21 shared papers)Sharon P. Wilczynski (1 shared paper)William M. Murphy (1 shared paper)
- Journals
- The Journal of Urology (7 papers)Journal of the American Society of Nephrology (6 papers)JCI Insight (6 papers)Human Pathology (5 papers)American Journal of Physiology-Renal Physiology (5 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Sheldon Bastacky
123 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 135
- Nephrology 569
- Urology 336
- Rheumatology 533
- Pulmonary and Respiratory Medicine 868
- Immunology 546
Countries citing papers authored by Sheldon Bastacky
This map shows the geographic impact of Sheldon Bastacky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheldon Bastacky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheldon Bastacky more than expected).
Fields of papers citing papers by Sheldon Bastacky
This network shows the impact of papers produced by Sheldon Bastacky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheldon Bastacky. The network helps show where Sheldon Bastacky may publish in the future.
Co-authors
The 25 scholars most cited alongside Sheldon Bastacky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 210 | |
| 2 | 2019 | 157 | |
| 3 | 2002 | 144 | |
| 4 | 1993 | 138 | |
| 5 | 2006 | 121 | |
| 6 | 2017 | 101 | |
| 7 | 2004 | 100 | |
| 8 | 2002 | 96 | |
| 9 | 1995 | 95 | |
| 10 | 1995 | 90 | |
| 11 | 2000 | 88 | |
| 12 | 2008 | 82 | |
| 13 | 2020 | 75 | |
| 14 | 2010 | 75 | |
| 15 | 2017 | 74 | |
| 16 | 2011 | 68 | |
| 17 | 2008 | 67 | |
| 18 | 2008 | 66 | |
| 19 | 2000 | 66 | |
| 20 | 2023 | 60 |
About Sheldon Bastacky
Sheldon Bastacky is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Nephrology and Rheumatology, having authored 123 papers that have together received 3.7k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (14 papers), Renal and related cancers (14 papers), Bladder and Urothelial Cancer Treatments (13 papers), Renal cell carcinoma treatment (10 papers), T-cell and B-cell Immunology (10 papers), Systemic Lupus Erythematosus Research (10 papers), Urinary Bladder and Prostate Research (9 papers) and Chronic Kidney Disease and Diabetes (9 papers). The work is most often cited by research in Nephrology (569 citations), Urology (336 citations), Rheumatology (533 citations), Pulmonary and Respiratory Medicine (868 citations) and Immunology (546 citations). Sheldon Bastacky has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Patrick C. Walsh, Jonathan I. Epstein, John P. Johnson, Youhua Liu, Stevan P. Tofovic, Rajiv Dhir, Sharon P. Wilczynski, William M. Murphy, Dong Zhou and Anil V. Parwani. Their work appears in journals such as The Journal of Urology, Journal of the American Society of Nephrology, JCI Insight, Human Pathology and American Journal of Physiology-Renal Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.